Joseph Shulman
Chief Tech/Sci/R&D Officer presso RHYTHM PHARMACEUTICALS, INC.
Patrimonio netto: 1 300 $ in data 31/03/2024
Profilo
Joseph Shulman's current job is Chief Technical Officer at Rhythm Pharmaceuticals, Inc. His former jobs include Senior Vice President-Technical Operations at Ra Pharmaceuticals, Inc. and Senior Vice President-Global Technical Operations at Novelion Therapeutics, Inc. He holds an MBA from Boston University and an undergraduate degree from the University of Miami.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 21/03/2024 | 30 ( 0.00% ) | 1 300 $ | 31/03/2024 |
Posizioni attive di Joseph Shulman
| Società | Posizione | Inizio |
|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 27/07/2020 |
Precedenti posizioni note di Joseph Shulman
| Società | Posizione | Fine |
|---|---|---|
| RA PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01/07/2020 |
| NOVELION THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | 01/07/2019 |
Formazione di Joseph Shulman
| Boston University | Masters Business Admin |
| University of Miami | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| RHYTHM PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Ra Pharmaceuticals, Inc.
 Ra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ra Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of peptide-based drugs. It uses Extreme Diversity platform that allows to produce synthetic macrocyclic peptides. The company was founded by James W. Broderick and Douglas A. Treco on June 27, 2008 and is headquartered in Cambridge, MA. | Health Technology |
Novelion Therapeutics, Inc.
 Novelion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Novelion Therapeutics, Inc. engaged in the development and commercialization of pharmaceuitical products. It focused in providing new standards of care for individuals living with rare diseases. The company was founded on February 3, 1981 and was headquartered in Vancouver, Canada. | Health Technology |
- Borsa valori
- Insiders
- Joseph Shulman
